| Date | Investigators | Affiliation | Project Title |
June 2009, due December 2009
Full project application
|
Margaret Cummings, Joanne Young, Mark Jenkins, Dan Buchanan, Michael Walsh, Sunil Lakhani
|
QIMR, Royal Brisbane Hospital & The University of Melbourne
|
Immunohistochemical analysis of mismatch repair (MMR) proteins in familial and
|
September 2009, due March 2010
pilot application
|
Stephen Fox & Gillian Mitchell
|
Peter MacCallum Cancer Centre, Melbourne
|
The identification of BRCA germline mutations using immunhistochemistry
|
September 2009, due March 2010
full application
|
Sunil Lakhani
|
Royal Brisbane Hospital, Brisbane
|
Expression of CT-X antigens in familial breast cancer
|
Nov 2009 Due May 2010
Full Application
|
Paul James, Gillian Mitchell, Alison Trainer, Judy Kirk, John Hopper; Melissa Southey, Stephen Fox, Ian Campbell
|
Peter MacCallum Cancer Centre, University of Melbourne, Westmead Hopital Sydney
|
Focus on pancreatic cancer
|
November 2009, due May 2010
Full application
|
Kelly Phillips, John Hopper, Michael Friedlander, Sue-Anne McLachlan, Roger Milne, David Goldgar
|
PeterMacCallum Cancer centre, Prince of Wales Sydney, The University of Melbourne, Spanish National Cancer Centre, IBCCS, Utah
|
Breast Cancer Risk in kConFab Women Known to be Negative for a Family Mutation in BRCA1 or BRCA2
|
December 2009, due June 2010
Full application
|
Melissa Southey & David Goldgar
|
The University of Melbourne & The Utah University, USA
|
Breast Cancer Susceptibility Gene Discovery through targeted and whole exome sequencing in High-risk BCFR families.
|
February 2010
Pilot application
|
Ashok Venkitaraman et al
|
Hutchison/MRC Research Centre, University of Cambridge, UK
|
Germline BRCA2 mutation carriers are at an increased risk of pancreatic ductal adenocarninoma.
|
A pilot or full application must be made within 6 months of submitting the letter
of intent. If more than six months has elapsed, a new letter of intent must be submitted
prior to the full application.
